Attached files
| file | filename |
|---|---|
| EX-10.50 - DESCRIPTION OF COMPENSATORY ARRANGEMENT WITH THOMAS BACHINSKI - NEUROONE MEDICAL TECHNOLOGIES Corp | fs12018a1ex10-50_neuroone.htm |
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - NEUROONE MEDICAL TECHNOLOGIES Corp | fs12018a1_neuroonemedical.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
NeuroOne Medical Technologies Corporation
Eden Prairie, Minnesota
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated April 16, 2018, relating to the consolidated financial statements of NeuroOne Medical Technologies Corporation, which is contained in that Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Minneapolis, Minnesota
October 29, 2018